Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitelcapitalpartners.com
Phone(212) 675-7755
Emailinfo@lcapitalpart...
Employees

Funds

Offices

New York Office
10 East 53rd Street
37th Floor
New York, NY, 10022
USA
Tel Aviv Office
9 Ahad Ha'am Street
Shalom Tower
Tel-Aviv, 65251, ISR

People

Investor Team
Investor Team
Investor Team
Investor Team
Investor Teamr
Investor Team
Investor Team
Investor Team

Tags

L Capital Partners

L Capital Partners is a $165-million fund looking to advance companies with the potential to take groundbreaking products to market. This mission is clearly reflected in their portfolio of healthcare, technology and energy & environment companies with their unique value propositions. To help these companies realize the promise of transformational change they are a committed, multi-round investor that supports each company with a team of partners, principals and associates who have deep industry expertise and financial acumen.

In the healthcare sector, they target investments in the areas of biopharmaceuticals and medical devices, and are particularly interested in companies in which the areas of drugs and devices intersect. In the technology sector, they primarily target companies in security/defense (homeland security) and information technology. The energy & environment sector is an emerging area for us, and, in general, they are looking for companies that could improve the quality of life.

Recent Milestones

Investments

Company Date Round Size Participants
Intrapace 4/2012Partial Close$2.25M2
CeNeRx BioPharma 2/2012Series D$4.6M3
CeNeRx BioPharma 8/2010Series C$13M3
iScience Interventional 5/2009Series F$20.5M8
WiSpry 4/2009Series C$10M8
Evogen 11/2008Series B$3M2
Simparel 6/2008Series A$4M1
WiSpry 3/2008Series B$18M3
Tengion 10/2007Series C$33M9
Hi-G-Tek 9/2006Venture Round$10M3
Tengion 6/2006Series B$50M7
Tengion 8/2005Series A$39M4

Videos

Sources

  1. SEC (sec.gov) [edit]
  2. CeNeRx BioPharma, Inc.: Series D $4.6M (onbiovc.com) [edit]
  3. CENERX BIOPHARMA COMPLETES $13 MILLION SERIES C FINANCING (cenerx.com) [edit]
  4. iScience Interventional, Inc.: Series F $20.5M (onbiovc.com) [edit]
  5. WiSpry Raises $10 Million (pehub.com) [edit]
  6. L Capital Partners Leads $3 Million Financing of Evogen, Inc. (evogen.com) [edit]
  7. L Capital Partners Invests 4 Million in Simparel : ERP Solutions (fashionnewspaper.com) [edit]
  8. Company Press Release (wispry.com) [edit]
  9. Tengion Closes $33 Million in Series C Funding Deerfield Partners Joins Investor Group as Company Advances Novel Regenerative Medicine Products (tengion.com) [edit]
  10. Battelle Ventures, L Capital Partners Invest in Hi-G-Tek, Inc.; Developer of Active-RFID Platform for Physical-Asset Monitoring, Control Secures $10 Million (findarticles.com) [edit]
  11. Tengion Inc. Completes $50 Million Series "B" Round Financing led by Bain Capital and Quaker BioVentures will support neo-bladder clinical trials, manufacturing capacity and pipeline development (tengion.com) [edit]
  12. Tengion Inc. Completes $39 Million Series "A" Round Financing Will Advance Development of Regenerative Medicine Products (phx.corporate-ir.net) [edit]
Edit This Page
Last Edited 3/11/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy